Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

White House Recommends 7-Year Data Exclusivity Period for Follow-on Biologics

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- Reuters reports that the White House sent a letter to Rep. Henry Waxman (D-CA), the Chairman of the House Energy and Commerce Committee, on Thursday stating that a follow-on biologics regulatory pathway providing a 7-year data exclusivity period would "strike[] the appropriate balance between innovation and competition." According to the Reuters report, the letter was signed by Peter Orszag, Director of the Office of Management and Budget (OMB), and Nancy-Ann DeParle, director of the Office of Health Reform. Three follow-on biologics bills have been introduced in the 111th Congress so far: H.R. 1427, which was introduced...

Full post as published by Patent Docs on June 26, 2009 (boomark / email).